CD4 and infection: As previously reported in Archary et al. (14), the women in both the tenofovir and placebo arms were similar in terms of their age, level of education, numbers of sexual partners, condom use, use of hormonal contraception, and disease progression markers such as CD4+ T cell counts and viral loads at 6 months post-infection (Table 1).